Access in all areas? A round-up of developments in market access and health technology assessment: part 14
In this update we examine the selection of 15 drugs for the third cycle of Medicare price negotiations under the Inflation Reduction Act and analyze emerging evidence of the Most-Favored-Nation impact on global pharmaceutical access, including launch delays and market withdrawals. We also review r...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Becaris Publishing Limited
2026-03-01
|
| Reeks: | Journal of Comparative Effectiveness Research |
| Onderwerpen: | |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|